Phytotherapy versus hormonal therapy for postmenopausal bone loss: a meta-analysis

This meta-analysis included 14 randomized controlled trials involving 780 patients to compare phytotherapy with hormonal therapy in the treatment of postmenopausal bone loss. Current evidence suggests that phytotherapy may possess a similar effect on bone mineral density (BMD) values but clinically is not associated with a high incidence of uterine bleeding and breast pain as is hormonal therapy. Clinical trials indicate that phytotherapy may be a potential treatment for postmenopausal osteoporosis. The objective of this meta-analysis was to compare the efficacy and safety of phytotherapy with that of hormonal therapy, to assess the quality of phytotherapy trials, and to identify herbs used commonly in the treatment of postmenopausal bone loss. A total of 43 electronic databases were searched. The quality of eligible trials was assessed using Jadad’s scale. Outcome measures were BMD values and adverse events. Revman 5.0 software was used for data syntheses and meta-analyses. The database search revealed 14 randomized controlled trials involving 780 patients that met the inclusion criteria, and four trials were graded as high quality (score 3–5). There was no significant difference in lumbar, femoral or forearm BMD values between subjects treated with phytotherapy and those treated with hormonal therapy (P>0.05), but the incidence of uterine bleeding and breast pain was significantly lower in those treated with phytotherapy than in those treated with hormonal therapy (P = 0.002 and P = 0.01). The six most commonly used herbs in the included trials were identified. Phytotherapy may not show effects beyond hormonal therapy, but may be safer than hormonal therapy in the treatment of postmenopausal bone loss. Further trials with high-quality study designs should be conducted in this field. Similar content being viewed by others

Bonjour JP, Ammann P, Rizzoli R (1999) Importance of preclinical studies in the development of drugs for treatment of osteoporosis: a review related to the 1998 WHO guidelines. Osteoporos Int 9:379–393 da Silva JA, Porto A (1997) Sex hormones and osteoporosis: a physiological perspective for prevention and therapy. Acta Med Port 10:689–695 Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333 Cai L, Li H, Wei Y (1998) Effect of Yang-Xue Bu-Shen tablet on ovarian function in animal model of Yang-deficiency. Chin J Integr Tradit West Med 18:620–622 Huang HF, You JS (1997) The use of Chinese herbal medicine on experimental fracture healing. Am J Chin Med 25:351–356 Zhang W, Leonard T, Bath-Hextall F et al (2004) Chinese herbal medicine for atopic eczema. Cochrane Database of Systematic Reviews, Issue 4. Art. no. CD002291. DOI 10.1002/14651858.CD002291.pub3 Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12 Xu M, Lee DTS, Xie JH et al (2007) A database on treating drug addiction with traditional Chinese medicine. Addiction 102:282–288 Ruan XY, Qi JM, Liu YL et al (2006) Effects of traditional Chinese medicine on bone mineral density and femoral neck strength in postmenopausal women. Chin J Osteoporos 12:181–184 Zhao G, Xu ZL, Shao QX et al (2004) A comparison of Livial and Qiang-Gu capsule in the prevention and treatment of postmenopausal osteoporosis. Chin J Osteoporos 10:337–339 Lu ZD, Wang SY (2004) Clinical observations on Gu-Shu-Kang pill in the treatment of osteoporosis. Chin J Clin Rehabil 8:3652 Liao L, Li XS, Cai QH et al (2004) Clinical research of Bu-Shen Sheng-Sui decoction in the treatment of postmenopausal osteoporosis. Chin J Inf Tradit Chin Med 11:287–290 Fan HX, Fan HZ, Wang ZH (2004) Clinical observations on the therapeutic effects of Geng-Nian An-Yi tablet for postmenopausal osteoporosis. Tianjin J Tradit Chin Med 21:20–21 Zhao LN (2003) Clinical research of Herba Epimedii in the prevention and treatment of osteoporosis. Mod J Integr Tradit Chin West Med 12:922–923 Song XW, Shen PZ, Chen BX (2001) Bu-Shen Huo-Xue formula in the treatment of postmenopausal osteoporosis. Chin J Orthop Traumatol 14:476 Chen YQ, Huang YH (2001) Clinical research of Jia-Rong tablet in the treatment of postmenopausal osteoporosis. Chin Contemp Med 7:57–58 Zhang GM, Guan SY, Wang WZ (2001) Clinical research of Xian-Gu-Ning powder in the treatment of postmenopausal osteoporosis. Acta Chin Med Pharmacol 29:31–32 Yang YP, Shen L, Xie J et al (2000) The effects of Mi-Gu tablet on bone mineral density for postmenopausal women. J Tradit Chin Orthop Traumatol 12:5–6 Xu M (2000) The effect of a herbal capsule (MG-2) in postmenopausal Chinese women with low bone density at the lumber spine: a randomized, placebo-controlled, double-blind clinical trial. PhD Thesis. The University of Western Australia, Australia Zhou PQ, Shen L, Yang YP et al (1997) Clinical research on the effects of Mi-Gu tablet in postmenopausal osteoporosis. Chin J Tradit Med Traumatol Orthop 5:20–22 Shi Q (1996) Clinical research of Bu-Shen Tian-Jing powder in the prevention and treatment of postmenopausal osteoporosis. Shanghai J Tradit Chin Med 10:2–7 Huang YH, Ye XQ (1993) The effects of tonic herbs in treatment of postmenopausal osteoporosis. Chin J Integr Tradit West Med 13:522–524, 515 Higgins JPT, Green S (eds) (2006) Cochrane handbook for systematic reviews of interventions 4.2.6 (updated September 2006). http://www.cochrane.org/resources/handbook/Handbook4.2.6Sep2006.pdf. Accessed 3 Sept 2008 Christiansen C (1993) Prevention and treatment of osteoporosis with hormone replacement therapy. Int J Fertil Menopausal Stud 38 [Suppl 1]:45–54 Warming L, Ravn P, Nielsen T et al (2004) Safety and efficacy of drospirenone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis. Climacteric 7:103–111 Warming L, Ravn P, Spielman D et al (2004) Trimegestone in a low-dose, continuous-combined hormone therapy regimen prevents bone loss in osteopenic postmenopausal women. Menopause 11:337–342 Xu M, Dick IM, Day R et al (2003) Effects of a herbal extract on the bone density, strength and markers of bone turnover of mature ovariectomized rats. Am J Chin Med 31:87–101 Xu M, Zhang XH, Liu SX (2002) Phytoestrogens in herbal medicine. Chin Drug Res Clin Pharmacol 13:261–263 Setchell KD, Lydeking-Olsen E (2003) Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 78:593S–609S Fanti P, Monier-Faugere MC, Geng Z et al (1998) The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos Int 8:274–281 Ishida H, Uesugi T, Hirai K et al (1998) Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol Pharm Bull 21:62–66 Nikander E, Metsa-Heikkila M, Ylikorkala O et al (2004) Effects of phytoestrogens on bone turnover in postmenopausal women with a history of breast cancer. J Clin Endocrinol Metab 89:1207–1212 Cotter A, Cashman KD (2003) Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy. Nutr Rev 61:346–351 Chen YM, Ho SC, Lam SS et al (2003) Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 88:4740–4747 Chen YM, Ho SC, Lam SS et al (2004) Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: a double-blind, randomized, controlled trial. Menopause 11:246–254 Atkinson C, Compston JE, Day NE et al (2004) The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 79:326–333 Wuttke W, Seidlova-Wuttke D, Gorkow C (2003) The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 44:S67–S77 Chen L, Zhu CY, Xu M et al (2004) Quality evaluation of clinical trial articles of postmenopausal osteoporosis treated with Chinese medicine. J Evid Based Med 4:141–144 Bennett JA (2005) The Consolidated Standards of Reporting Trials (CONSORT): guidelines for reporting randomized trials. Nurs Res 54:128–132 Strand V, Gladman D, Isenberg D et al (2000) Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology. Lupus 9:322–327

This project was supported by a grant under the 973 Plan of the Chinese Government (2005CB523502) and a Faculty Research Grant from Hong Kong Baptist University (FRG/0304/I57). The authors acknowledge the assistance of Professor Zhao Zhongzhen and Dr. Ou Tong at Hong Kong Baptist University in providing herbal pictures. Conflicts of interest None. Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Xu, M., Qi, C., Deng, B. et al. Phytotherapy versus hormonal therapy for postmenopausal bone loss: a meta-analysis. Osteoporos Int 20, 519–526 (2009). https://doi.org/10.1007/s00198-008-0724-x Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00198-008-0724-x